Werewolf Therapeutics, Inc. (HOWL) vs Rapid Micro Biosystems, Inc. (RPID)
A side-by-side comparison of Werewolf Therapeutics, Inc. and Rapid Micro Biosystems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HOWL
Werewolf Therapeutics, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
RPID
Rapid Micro Biosystems, Inc.
$0.98HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT
Total return — HOWL vs RPID
growth of $100 · dividends reinvested · last 5yHOWL -94.1% (-43.2%/yr)RPID -95.4% (-46.1%/yr)HOWL compounded faster over this window
HOWL RPID
HOWL vs RPID: by the numbers
- •HOWL is the larger company ($45M vs $45M market cap).
- •Both run net losses; RPID's is the smaller (-145.56% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | HOWL | RPID |
|---|---|---|
| P/S ratio | 2.15 | 1.27 |
| P/B ratio | 2.77 | 2.51 |
Profitability
| Metric | HOWL | RPID |
|---|---|---|
| Gross margin | 0.00% | 22.65% |
| Operating margin | 0.00% | -141.45% |
| Net margin | -164.82% | -145.56% |
| ROE | -212.45% | -288.49% |
| ROIC | -156.97% | -123.47% |
Growth (annualized)
| Metric | HOWL | RPID |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 10.24% |
| Total return CAGR (5Y) | -44.27% | -44.09% |
Frequently asked
- How have HOWL and RPID total returns compared?
- Over the past 5 years, HOWL delivered -44.27% and RPID delivered -44.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.